Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun 1;2013(17):10.1002/ejic.201300254.
doi: 10.1002/ejic.201300254.

Mechanistic Studies on the Reaction of Nitrocobalamin with Glutathione: Kinetic evidence for formation of an aquacobalamin intermediate

Affiliations

Mechanistic Studies on the Reaction of Nitrocobalamin with Glutathione: Kinetic evidence for formation of an aquacobalamin intermediate

David T Walker et al. Eur J Inorg Chem. .

Abstract

The essential but also toxic gaseous signaling molecule nitric oxide is scavenged by the reduced vitamin B12 complex cob(II)alamin. The resulting complex, nitroxylcobalamin (NO--Cbl(III)), is rapidly oxidized to nitrocobalamin (NO2Cbl) in the presence of oxygen; however it is unlikely that nitrocobalamin is itself stable in biological systems. Kinetic studies on the reaction between NO2Cbl and the important intracellular antioxidant, glutathione (GSH), are reported. In this study, a reaction pathway is proposed in which the β-axial ligand of NO2Cbl is first substituted by water to give aquacobalamin (H2OCbl+), which then reacts further with GSH to form glutathionylcobalamin (GSCbl). Independent measurements of the four associated rate constants k1, k-1, k2, and k-2 support the proposed mechanism. These findings provide insight into the fundamental mechanism of ligand substitution reactions of cob(III)alamins with inorganic ligands at the β-axial site.

Keywords: Bioinorganic chemistry; Cob(III)alamin; Kinetics; Reaction mechanisms; Vitamin B12.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structure of cobalamins showing the two axial sites (upper = β, lower = α) with respect to the corrin ring.
Figure 2
Figure 2
(a) UV-vis spectra for the reaction of GSH (5.00 × 10−2 M) with NO2Cbl (5.0 × 10−5 M) at pH 4.00 (25.0 °C, 0.020 M NaOAc, I = 1.0 M, NaCF3SO3). Selected spectra for the reaction are shown every 1.00 min. (b) Plot of absorbance at 354 nm versus time for the experiment shown in 2(a). Data were fitted to a first-order rate equation, giving kobs = (1.15 ± 0.07) × 10−2 s−1.
Figure 3
Figure 3
Plots of kobs vs [GSH] at pH 4.00 (a) and 7.00 (b) for the reaction between NO2Cbl (5.00 × 10−5 M) and glutathione (25.0 °C, 0.020 M NaOAc (a) or 0.020 M KH2PO4 (b), I = 1.0 M (NaCF3SO3)). Data in (a) were fitted to eq (2) in the text fixing k−2 = 7.4 × 10−4 s−1, giving k1 = (1.75 ± 0.02) × 10−2 s−1 and K = 94.5 ± 3.7 M−1 at pH 4.00. Data in (b) were fitted to eq (2) fixing k−2 = 0 s−1, giving k1 = (1.73 ± 0.05) × 10−2 s−1 and K = 102.1 ± 9.7 M−1 at pH 7.00.
Figure 4
Figure 4
Plot of kobs vs [GSH] for the reaction between NO2Cbl (5.0 × 10−5 M) and GSH in the presence of 5.00 × 10−4 M NaNO2 at pH 7.00 (25.0°C, 0.020 M KH2PO4, 5.00×10−4 M NaNO2, I = 1.0 M, NaCF3SO3). Data were fitted to eq (2) in the text fixing k−2 = 0, giving k1 = (1.60 ±0.05) × 10−2s−1 and K = 16.2 ± 0.2 M−1.
Scheme 1
Scheme 1
Proposed reaction pathway for the reaction of NO2Cbl with GSH. Note that in aqueous solution H2OCbl+ exists in equilibrium with HOCbl (pKa(H2OCbl+) = 7.8 [17]); however at the pH conditions of our kinetic experiments HOCbl formation is unimportant, since the values of the rate constants k−1 and k2 are the same at pH 4.00 and 7.00.

Similar articles

Cited by

References

    1. Kräutler B, Ostermann S. In: The Porphyrin Handbook. Kadish KM, Smith KM, Guilard R, editors. Chapter 68. Academic Press; San Diego: 2003. p. 229.
    2. Banerjee R, editor. Chemistry and Biochemistry of B12. Wiley & Sons; New York: 1999.
    3. Brown KL. Chem Rev. 2005;105:2075. - PubMed
    1. Scalabrino G, Mutti E, Veber D, Aloe L, Corsi MM, Galbiati S, Tredici G. Neurosci Lett. 2006;396:153. - PubMed
    2. Scalabrino G, Peracchi M. Trends Mol Med. 2006;12:247. - PubMed
    3. Veber D, Mutti E, Tacchini L, Gammella E, Tredici G, Scalabrino G. J Neurosci Res. 2008;86:1380–1387. - PubMed
    4. Mukherjee R, Brasch NE. Chem - Eur J. 2011;17:11673.
    5. Birch CS, Brasch NE, McCaddon A, Williams JHH. Free Radical Biol Med. 2009;47:184. - PubMed
    6. Moreira ES, Brasch NE, Yun J. Radical Biol Med. 2011;51:876. - PMC - PubMed
    7. Suarez-Moreira E, Yun J, Birch CS, Williams JHH, McCaddon A, Brasch NE. J Am Chem Soc. 2009;131:15078. - PubMed
    1. Ignarro L. J Cardiovasc Pharmacol. 1999;34:879. - PubMed
    2. Heinecke J, Ford PC. Coord Chem Rev. 2010;254:235.
    3. Avery AA. Environ Health Perspect. 1999;107:583. - PMC - PubMed
    1. Carmen W. Med Hypotheses. 2006;67:124. - PubMed
    1. Rand MJ, Li CG. Eur J Pharmacol. 1993;241:249. - PubMed
    2. Greenberg SS, Xie J, Zatarain JM, Kapusta DR, Miller MJ. J Pharmacol Exp Ther. 1995;273:257. - PubMed
    3. Schubert R, [Krien U, Wulfsen I, Schiemann D, Lehmann G, Ulfig N, Veh RW, Schwarz JR, Gago H. Hypertension. 2004;43:891. - PubMed

LinkOut - more resources